Innovation
Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding | Entrepreneur
Can-Fite BioPharma Ltd. (NYSEAMERICAN: CANF) is an Israel-based biotechnology firm that develops small-molecule therapeutic treatments for cancers, inflammatory diseases and sexual dysfunction. It targets the A3 adenosine receptor (A3AR)...
7 Interview Questions to Build a Positive Work Culture | Entrepreneur
Opinions expressed by Entrepreneur contributors are their own. Creating a positive culture is more than putting a ping-pong table in the break room or free snacks.It's also about hiring...
Apple Card Savings Account Deposits Hit a Billion in 4 Days: Report | Entrepreneur
On April 17, Apple announced its new Apple Card Savings Account through Goldman Sachs. The savings account has no fees, minimum deposits, or balance requirements. Additionally, the account offers...
Ecolab: Slow And Steady Wins The Race | Entrepreneur
Ecolab (NYSE: ECL) has had its share of issues over the last 2 years, but those are centered on share prices which have retreated to reasonable levels. The stock...
Enjoy Lifetime Access to This Travel App’s Helpful Tools for the Best Price Online | Entrepreneur
Disclosure: Our goal is to feature products and services that we think you'll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the...
Why Embracing Change is the Best Catalyst for Growth | Entrepreneur
Opinions expressed by Entrepreneur contributors are their own. It's the human condition to find comfort. I like to pour a cup of tea, pull a blanket around my shoulders...
MGM’s Hot Hand Is All In For A Rally, After This Small Break | Entrepreneur
The Chinese have a saying concerning the reality of the haves and have-nots and how they should deal with their finances. Those who have riches or inherit them can...
High-Yield Pfizer Falls Off The COVID Cliff, And Survives | Entrepreneur
Pfizer (NYSE: PFE) was expected to post a significant decline in revenue and earnings because of the slowing COVID business, and it did. However, the takeaway from the report...
